Expression Profile Screening and Bioinformatics Analysis of Circrna, Lncrna and Mrna in Acute Myeloid Leukemia Drug-Resistance Cells
Acute myeloid leukemia (AML) is a highly heterogeneous hematological malignancy, drug resistance and relapse are key factors in the failure of leukemia treatment. More and more studies have shown that circRNA and LncRNA play an important role in the development of tumors, but it is remains unclear in the mechanism of AML resistance. AML resistant cell line HL-60/ADM (Adriamycin, ADM) was constructed, and circRNA, LncRNA and mRNA expression profiles were screened follow by high-throughput sequencing, then bioinformatics analysis was carried out, circRNA-miRNA ceRNA network was constructed, and confirmed using qRT-PCR analysis. A total of 1824 circRNA, 2414 LncRNA, and 5346 mRNA were screened as differentially expressed genes, GO and KEGG mainly involved that Protein domain specific binding, transforming growth factor-β (TGF-β) receptor and cellular metabolism. mTOR signaling pathway, MAPK signaling pathway, RAP1 signaling pathway and Akt signaling pathway were closely related to multidrug. Our study provides a systematic outlook on the potential function of ncRNA in the molecular mechanisms of AML resistant cells. Hsa-circ-0000978 and hsa-circ-0000483 might be served as potential prognostic biomarkers and therapeutic targets of AML resistance.